Completed PHASE4 INTERVENTIONAL 2-arm NCT00672776

Effects of Paxil CR on Neural Circuits in Posttraumatic Stress Disorder (PTSD)

Effects of Paxil CR on Neural Circuits in PTSD

Sponsor: Emory University

Conditions Posttraumatic Stress Disorder (PTSD)

Updated 6 times since 2017 Last updated: Feb 28, 2017 Started: May 31, 2003 Primary completion: Sep 30, 2007 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00672776, this PHASE4 trial focuses on Posttraumatic Stress Disorder (PTSD) and remains completed. Sponsored by Emory University, it has been updated 6 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

May 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Emory University

Data source: Emory University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.